| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/MED.2610130103 |
| P698 | PubMed publication ID | 8416263 |
| P2093 | author name string | Campbell WC | |
| P2860 | cites work | Avermectins, New Family of Potent Anthelmintic Agents: Producing Organism and Fermentation | Q24598202 |
| Avermectins, New Family of Potent Anthelmintic Agents: Isolation and Chromatographic Properties | Q36523586 | ||
| Avermectins, New Family of Potent Anthelmintic Agents: Efficacy of the B 1a Component | Q36523589 | ||
| Anthelmintic resistance by Haemonchus contortus to ivermectin in Brazil: a preliminary report. | Q52456927 | ||
| Resistance of field strains of Haemonchus contortus to ivermectin, closantel, rafoxanide and the benzimidazoles in South Africa. | Q52460264 | ||
| Prophylactic efficacy of milbemycin D against Dirofilaria immitis infection in dogs. | Q52467847 | ||
| Control of larvae of the common cattle grub (Diptera: Oestridae) with animal systemic insecticides. | Q52522654 | ||
| Resistance to ivermectin in a field strain of Ostertagia spp. in goats. | Q54321963 | ||
| Evidence for multiple anthelmintic resistance in two nematode parasite genera on a Saanen goat dairy. | Q54321972 | ||
| P433 | issue | 1 | |
| P921 | main subject | ivermectin | Q415178 |
| P304 | page(s) | 61-79 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Medicinal Research Reviews | Q2436033 |
| P1476 | title | Ivermectin, an antiparasitic agent | |
| P478 | volume | 13 |
| Q35861508 | A New Golden Age of Natural Products Drug Discovery |
| Q45920357 | A comparison of the effects of ivermectin and moxidectin on the nematode Caenorhabditis elegans. |
| Q50610896 | Advantages of an annual single dose of ivermectin 400 micrograms/kg plus diethylcarbamazine for community treatment of bancroftian filariasis. |
| Q74147806 | Antifilarial activity of some 2H-1-benzopyran-2-ones (coumarins) |
| Q52596089 | Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and sheep infected with mange. |
| Q46323457 | Comparative pharmacokinetics of ivermectin alone and a novel formulation of ivermectin and rafoxanide in calves and sheep |
| Q52553335 | Deaths after ivermectin treatment. |
| Q51747367 | Energetic costs of parasitism in the Cape ground squirrel Xerus inauris. |
| Q38884200 | Honoring antiparasitics: The 2015 Nobel Prize in Physiology or Medicine. |
| Q44893718 | Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi |
| Q41900002 | In vivo protection against strychnine toxicity in mice by the glycine receptor agonist ivermectin |
| Q48262198 | MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin |
| Q33774421 | New approaches to the treatment of canine demodicosis |
| Q34668871 | Observations on topical ivermectin in the treatment of otoacariosis, cheyletiellosis, and toxocariosis in cats. |
| Q52592300 | Pharmacokinetics of abamectin in horses. |
| Q37001435 | The challenges of developing novel antiparasitic drugs |
| Q35050066 | Topical (pour-on) ivermectin in the treatment of canine scabies |
| Q36851934 | Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions |
| Q52561601 | [The treatment of rats experimentally infected with Strongyloides venezuelensis by orally administered ivermectin] |
Search more.